It looks like your browser is not up to date.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Lonza Group AG (LONN) CHF1 (Regd)

Sell:562.00 CHF Buy:562.00 CHF Change: 2.40 CHF (0.42%)
Market closed |  Prices as at close on 18 May 2021 | Switch to live prices |
Sell:562.00 CHF
Buy:562.00 CHF
Change: 2.40 CHF (0.42%)
Market closed |  Prices as at close on 18 May 2021 | Switch to live prices |
Sell:562.00 CHF
Buy:562.00 CHF
Change: 2.40 CHF (0.42%)
Market closed |  Prices as at close on 18 May 2021 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Lonza Group AG (Lonza) is a Switzerland-based holding company and a supplier to the pharmaceutical, healthcare and life science industries. The Company's offerings include custom development and manufacturing of drugs and drug delivery systems, as well as development of anti-microbial solutions for commercial applications. The Company divides its activities into two segments: Pharma&Biotech; and Specialty Ingredients. The Pharma&Biotech; comprises the Company's Biologics, Small-Molecule, and Consumables and Research Tools businesses. The segment includes mammalian, microbial, chemical, bioconjugates, cell and gene therapy technology platforms. The Specialty Ingredients segment focuses on anti-microbial applications within Consumer Health division, which covers hygiene, nutrition and personal care products, as well as preservatives, capsules and food supplements, among others, and Consumer & Resources Protection division, which includes coatings and composites, and agro ingredients.

Contact details

Muenchensteinerstrasse 38
+41 (61) 3168111

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
42.12 billion CHF
Shares in issue:
74.10 million
Life Sciences Tools & Services
SIX Swiss Exchange
Swiss Franc
Swiss Market Index

Key personnel

  • Albert Baehny
    Independent Chairman of the Board
  • Pierre-Alain Ruffieux
    Chief Executive Officer, Member of the Executive Committee
  • Rodolfo Savitzky
    Chief Financial Officer, Member of the Executive Committee
  • Caroline Barth
    Chief Human Resource Officer, Member of the Executive Committee
  • Stefan Stoffel
    Chief Operating Officer of Lonza Pharma Biotech and Nutrition, Member of the Executive Committee

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.